CLINICAL TRIALS PROFILE FOR AZD9977
✉ Email this page to a colleague
Clinical Trials for AZD9977
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT02484729 ↗ | A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 After Single Ascending Doses to Healthy Males | Completed | AstraZeneca | Phase 1 | This study will be a randomized, single-blind, placebo-controlled first-in-human study in healthy male subjects to assess the safety, tolerability and pharmacokinetics of single ascending doses of AZD9977. In Part B of this study the regional absorption of AZD9977 along the gastro-intestinal tract will be investigated using the IntelliCap® system in a non-randomized, open-label, fixed-sequence design. The study will be performed at a single study centre. |
NCT02532998 ↗ | A Study to Assess the Pharmacodynamic Effect of Single Doses of AZD9977 in Healthy Male Subjects | Completed | AstraZeneca | Phase 1 | This is a Phase I, Randomized, Single-Blind, Crossover Study to Assess the Pharmacodynamics of AZD9977 following Single-Dose administration to healthy male subjects |
NCT02560363 ↗ | A Study to Compare the Pharmacokinetics of Different Formulations of AZD9977 and the Influence of Food in Healthy Male Subjects | Withdrawn | AstraZeneca | Phase 1 | This is an open-label, randomized, cross over single oral dose study to compare the pharmacokinetics of different formulations of AZD9977 in Part A and the influence of food in Part B in healthy male subjects |
NCT03435276 ↗ | Multiple-ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 in Healthy Male Subjects | Completed | Parexel | Phase 1 | This is a randomized, single-blind, placebo-controlled study conducted on healthy male subjects at a single study center to assess the safety, tolerability and the pharmacokinetics of AZD9977 following multiple-ascending oral doses at steady state |
NCT03435276 ↗ | Multiple-ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 in Healthy Male Subjects | Completed | AstraZeneca | Phase 1 | This is a randomized, single-blind, placebo-controlled study conducted on healthy male subjects at a single study center to assess the safety, tolerability and the pharmacokinetics of AZD9977 following multiple-ascending oral doses at steady state |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for AZD9977
Condition Name
Clinical Trial Locations for AZD9977
Trials by Country
Clinical Trial Progress for AZD9977
Clinical Trial Phase
Clinical Trial Sponsors for AZD9977
Sponsor Name